163 related articles for article (PubMed ID: 32458383)
1. On barring the vascular gateway against severe COVID-19 disease.
Perdrizet G; Hightower LE
Cell Stress Chaperones; 2020 Sep; 25(5):721-723. PubMed ID: 32458383
[No Abstract] [Full Text] [Related]
2. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
De Maio A; Hightower LE
Cell Stress Chaperones; 2020 Sep; 25(5):717-720. PubMed ID: 32424591
[No Abstract] [Full Text] [Related]
3. UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
Undersea Hyperb Med; 2020; 47(2):297-298. PubMed ID: 32574446
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen as a treatment for COVID-19 infection?
Moon RE; Weaver LK
Undersea Hyperb Med; 2020; 47(2):177-179. PubMed ID: 32574432
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
Guo D; Pan S; Wang M; Guo Y
Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433
[TBL] [Abstract][Full Text] [Related]
6. Proactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center.
Lo JJ; Wang SC; Lee HY; Lee SS; Lee HC; Hung CT; Huang SH
Medicina (Kaunas); 2020 May; 56(6):. PubMed ID: 32471203
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free Therapies: Novel Approaches for COVID-19.
Maron-Gutierrez T; Rocco PRM
Front Immunol; 2020; 11():583017. PubMed ID: 33072130
[No Abstract] [Full Text] [Related]
8. Passive antibody therapy in COVID-19.
Abraham J
Nat Rev Immunol; 2020 Jul; 20(7):401-403. PubMed ID: 32533109
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and management of neuroimmunological disorders.
Hartung HP; Aktas O
Nat Rev Neurol; 2020 Jul; 16(7):347-348. PubMed ID: 32444648
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 antibodies on trial.
DeFrancesco L
Nat Biotechnol; 2020 Nov; 38(11):1242-1252. PubMed ID: 33087898
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
13. HBO2 for COVID-19: Clinical trials at clinicaltrials.gov.
Undersea Hyperb Med; 2020; 47(2):299-307. PubMed ID: 32574447
[No Abstract] [Full Text] [Related]
14. Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?
Nilashi M; Samad S; Yusuf SYM; Akbari E
J Infect Public Health; 2020 Jun; 13(6):893-896. PubMed ID: 32451258
[No Abstract] [Full Text] [Related]
15. Plasma Therapies and Parabiosis in the COVID-19 Era.
Calvani R; Picca A; Landi F; Marzetti E
J Am Med Dir Assoc; 2020 Jul; 21(7):994-995. PubMed ID: 32674834
[No Abstract] [Full Text] [Related]
16. Phages in the fight against COVID-19?
Górski A; Międzybrodzki R; Żaczek M; Borysowski J
Future Microbiol; 2020 Aug; 15():1095-1100. PubMed ID: 32845164
[No Abstract] [Full Text] [Related]
17. Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.
Belizário JE
Clinics (Sao Paulo); 2020; 75():e2124. PubMed ID: 32667492
[No Abstract] [Full Text] [Related]
18. COVID-19: a case for inhibiting IL-17?
Pacha O; Sallman MA; Evans SE
Nat Rev Immunol; 2020 Jun; 20(6):345-346. PubMed ID: 32358580
[TBL] [Abstract][Full Text] [Related]
19. The convalescent sera option for containing COVID-19.
Casadevall A; Pirofski LA
J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
[No Abstract] [Full Text] [Related]
20. Treatment of COVID-19: old tricks for new challenges.
Cunningham AC; Goh HP; Koh D
Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
